This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Ludmila Schechtman: Innovator in Schizophrenia Diagnosis
Introduction
Ludmila Schechtman is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of medical diagnostics, particularly in relation to schizophrenia. Her innovative work has led to the development of a unique patent that addresses critical aspects of this mental health condition.
Latest Patents
Ludmila holds a patent for "Peptide combinations for use in the diagnosis of schizophrenia." This patent includes a composition that features a combination of at least one short peptide and at least one peptide dimer, in a defined ratio. These components are designed to bind with autoantibodies found in elevated levels in patients diagnosed with schizophrenia. This innovative approach has the potential to enhance diagnostic accuracy and improve patient outcomes.
Career Highlights
Ludmila Schechtman is associated with Yeda Research and Development Co. Ltd., where she has been instrumental in advancing research initiatives. Her work has not only contributed to scientific knowledge but has also paved the way for practical applications in the medical field.
Collaborations
Throughout her career, Ludmila has collaborated with notable colleagues, including Meir Shinitzky and the late Meir Shinitzky. These collaborations have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Ludmila Schechtman's innovative contributions to the diagnosis of schizophrenia exemplify her dedication to advancing medical science. Her patent and collaborative efforts highlight the importance of research in improving mental health diagnostics.